ARG1 and pulmonary fibrosis: In addition, arginase (Arg)1 (3.85-fold change and p < 0.01) and Arg2 (1.79-fold change and p < 0.01), which are known to be involved in the development of lung fibrosis, were increased in the PHMG-P-treated group.